Advanced Therapeutics Train C specialty-CDMO capacity is scheduled to come online in spring 2027, beginning revenue generation at the new facility.
Initial U.S. pharma reshoring orders, including five top-10 pharma companies, are expected to start converting into revenue in fiscal 2027.
The Altura consumables column family is being expanded into additional biopharma workflows, with further use cases planned in coming quarters.
Agilent's new China Innovation Center is starting lab-automation software co-development with a commercial testing customer ahead of a fully automated lab deployment.
Biocare's clinically focused antibody menu is being integrated into Agilent's pathology business and is included in the fiscal fourth-quarter revenue guide.
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Agilent Technologies, Inc. and 4,900+ companies.